StockMarketWire.com - finnCap today reaffirms its corporate investment rating on Allergy Therapeutics PLC [LON:AGY] and cut its price target to 40p (from 47p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk